Cointime

DesignMedix

company

About

DesignMedix develops pharmaceutical drugs designed to address the rapid rise in drug resistance in multiple diseases.

  • 1 - 10

Highlights

Total Funding Amount
$5.67M
Funding Rounds
3
Investors
3

Details

Last Funding Type
Grant
Last Funding Money Raised
$3M
Industries
Biotechnology,Health Diagnostics,Medical
Founded date
Jan 1, 2006
Number Of Employee
1 - 10
Operating Status
Active

DesignMedix develops pharmaceutical drugs designed to address the rapid rise in drug resistance in multiple diseases. Its drugs are developed by covalently linking a chemical moiety derived from a resistance reversal agent in order to fulfill the roles of both therapeutic agent and resistance reversal agent, enabling medical practitioners to treat malaria and other infectious diseases without a hassle.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$5.67M
DesignMedix has raised a total of $5.67M in funding over 2 rounds. Their latest funding was raised on Apr 15, 2014 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 15, 2014 Grant $3M 1 National Institutes of Health — Detail
Jun 17, 2010 Series Unknown $1.17M 1 Northwest Technology Ventures — Detail
Apr 17, 2007 Series A $1.50M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
2
3
DesignMedix is funded by 3 investors. National Institutes of Health and Northwest Technology Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Northwest Technology Ventures Yes Series Unknown
Keiretsu Forum — Series A
Cointime
เนื้อหา
บริษัท